Factors Associated With Post-induction Hypotension in iNPH Patient Undergoing VP and LP Shunt
- Conditions
- The iNPH Patients Scheduled for VP or LP Shunt Procedures
- Interventions
- Drug: Ehedrine Norepineprine
- Registration Number
- NCT05183061
- Lead Sponsor
- Mahidol University
- Brief Summary
This study is a retrospective work involving the review of patients who were scheduled for VP or LP shunt in Siriraj Hospital, Mahidol University, Thailand. The sample size calculation was based on the rule of thumbs of the logistic regression comprising 18 risk factors. The incidence of post-induction hypotension according to our institution's pilot study November 2019-January 2020) was 47%. With 10% addition for missing data and other possible reasons, the sample size was 426. The primary objective of the study is to report the factors associated with post-induction hypotension in iNPH patients undergoing VP or LP shunt procedures. Our secondary objective is to determine the incidence of post-induction hypotension in these patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 426
- Elective cases of iNPH scheduled for VP and LP shunt
- Patients aged > 18 years old
- Emergency cases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Hypotensive group Ehedrine Norepineprine Hypotenson is defined as systolic blood pressure (SBP) \< 80 mmHg or a drop more than 20% from baseline SBP for longer than 10 minutes or a drop that requires treatment either vasopressor or inotropic drugs.
- Primary Outcome Measures
Name Time Method Factors associated with post-induction hypotension in iNPH patients undergoing VP or LP shunt procedures 9 months Risk factors associated with post-induction hypotension after administration of anesthetic agents
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Anesthesiology Department
🇹🇭Bangkok, Thailand